Evidence map›Paper›PMID 34745755›Full record

ArticleBiomedical optics express2021

Label-free skin penetration analysis using time-resolved, phase-modulated stimulated Raman scattering microscopy.

Terumasa Ito, Risa Iguchi, Fumiaki Matsuoka, Yoji Nishi, Tsuyoshi Ogihara, Kazuhiko Misawa

Abstract read
In one paragraph

Article in Biomedical optics express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Evaluating In Vivo Penetration of Yeast Rice Ferment Filtrate Into Skin Using Confocal Raman Microspectroscopy: A Pilot Study.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Terumasa ItoDepartment of Applied Physics, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.ORCID https://orcid.org/0000-0002-6549-2806
Risa IguchiMatsumoto Trading Co., Ltd., 1-13-7 Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-0022, Japan.
Fumiaki MatsuokaDepartment of Applied Physics, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.
Yoji NishiMatsumoto Trading Co., Ltd., 1-13-7 Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-0022, Japan.
Tsuyoshi OgiharaMatsumoto Trading Co., Ltd., 1-13-7 Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-0022, Japan.
Kazuhiko MisawaDepartment of Applied Physics, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.ORCID https://orcid.org/0000-0002-7150-2097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin penetration analysis of topically applied drugs or active compounds is essential in biomedical applications. Stimulated Raman scattering (SRS) microscopy is a promising label-free skin penetration analysis tool. However, conventional SRS microcopy suffers from limited signal contrast owing to strong background signals, which prevents its use in low-concentration drug imaging. Here, we present a skin penetration analysis method of topical agents using recently developed phase-modulated SRS (PM-SRS) microscopy. PM-SRS uses phase modulation and time-resolved signal detection to suppress both nonlinear background signals and Raman background signals from a tissue. A proof-of-concept experiment with a topically applied skin moisturizing agent (ectoine) in an

Identifiers

PMID34745755
PMCPMC8548008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.